Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanClinical drug
ado-trastuzumab emtansine 160 MG Injection [KADCYLA]
160 MG · Injection · injection
A form of ado-trastuzumab emtansine →
ado-trastuzumab emtansine 160 MG Injection [KADCYLA] — HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Strength, form, class, interactions & more.
![ado-trastuzumab emtansine 160 MG Injection [KADCYLA]](https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e&name=kadcyla-01.jpg)
Active ingredient
Classification
Drug interactions
Concomitant use of strong CYP3A4 inhibitors with ado-trastuzumab emtansine should be avoided due to potential increased toxicity.
- majorstrong CYP3A4 inhibitors — increased DM1 exposure and toxicity
Real-world adverse events (FAERS)
Source: RxNorm + openFDA + RxClass + FAERS · 2026
Look up another medication